Global Atrial Fibrillation Treatment Market Size, Status, Research and Forecast 2019-2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 352682

Atrial fibrillation is an abnormal heart rhythm characterized by rapid and irregular beating of the atria. Often it starts as brief periods of abnormal beating which become longer and possibly constant over time. Often episodes have no symptoms. Occasionally there may be heart palpitations, fainting, lightheadedness, shortness of breath, or chest pain. The disease is associated with an increased risk of heart failure, dementia, and stroke. It is a type of supraventricular tachycardia.
Geographically, the Americas is anticipated to dominate the global atrial fibrillation market owing to a the rise in the adoption of innovative technologies and procedures for the treatment of atrial fibrillation, and advanced healthcare facilities and infrastructure.
In 2018, the global Atrial Fibrillation Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Atrial Fibrillation Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Atrial Fibrillation Treatment development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson
Abbott
Medtronic
Boston Scientific
Siemens
Biotronik
Koninklijke Philips
AtriCure
CardioFocus
MicroPort Scientific
Sichuan Jinjiang Electronic Science and Technology

Market segment by Type, the product can be split into
Medications
Non-Surgical Procedures
Surgical Procedures

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Atrial Fibrillation Treatment status, future forecast, growth opportunity, key market and key players.
To present the Atrial Fibrillation Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Atrial Fibrillation Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Atrial Fibrillation Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Medications
1.4.3 Non-Surgical Procedures
1.4.4 Surgical Procedures
1.5 Market by Application
1.5.1 Global Atrial Fibrillation Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Atrial Fibrillation Treatment Market Size
2.2 Atrial Fibrillation Treatment Growth Trends by Regions
2.2.1 Atrial Fibrillation Treatment Market Size by Regions (2014-2025)
2.2.2 Atrial Fibrillation Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Atrial Fibrillation Treatment Market Size by Manufacturers
3.1.1 Global Atrial Fibrillation Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Atrial Fibrillation Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Atrial Fibrillation Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Atrial Fibrillation Treatment Key Players Head office and Area Served
3.3 Key Players Atrial Fibrillation Treatment Product/Solution/Service
3.4 Date of Enter into Atrial Fibrillation Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Atrial Fibrillation Treatment Market Size by Type (2014-2019)
4.2 Global Atrial Fibrillation Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Atrial Fibrillation Treatment Market Size (2014-2019)
5.2 Atrial Fibrillation Treatment Key Players in United States
5.3 United States Atrial Fibrillation Treatment Market Size by Type
5.4 United States Atrial Fibrillation Treatment Market Size by Application

6 Europe
6.1 Europe Atrial Fibrillation Treatment Market Size (2014-2019)
6.2 Atrial Fibrillation Treatment Key Players in Europe
6.3 Europe Atrial Fibrillation Treatment Market Size by Type
6.4 Europe Atrial Fibrillation Treatment Market Size by Application

7 China
7.1 China Atrial Fibrillation Treatment Market Size (2014-2019)
7.2 Atrial Fibrillation Treatment Key Players in China
7.3 China Atrial Fibrillation Treatment Market Size by Type
7.4 China Atrial Fibrillation Treatment Market Size by Application

8 Japan
8.1 Japan Atrial Fibrillation Treatment Market Size (2014-2019)
8.2 Atrial Fibrillation Treatment Key Players in Japan
8.3 Japan Atrial Fibrillation Treatment Market Size by Type
8.4 Japan Atrial Fibrillation Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Atrial Fibrillation Treatment Market Size (2014-2019)
9.2 Atrial Fibrillation Treatment Key Players in Southeast Asia
9.3 Southeast Asia Atrial Fibrillation Treatment Market Size by Type
9.4 Southeast Asia Atrial Fibrillation Treatment Market Size by Application

10 India
10.1 India Atrial Fibrillation Treatment Market Size (2014-2019)
10.2 Atrial Fibrillation Treatment Key Players in India
10.3 India Atrial Fibrillation Treatment Market Size by Type
10.4 India Atrial Fibrillation Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Atrial Fibrillation Treatment Market Size (2014-2019)
11.2 Atrial Fibrillation Treatment Key Players in Central & South America
11.3 Central & South America Atrial Fibrillation Treatment Market Size by Type
11.4 Central & South America Atrial Fibrillation Treatment Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Atrial Fibrillation Treatment Introduction
12.1.4 Johnson & Johnson Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Atrial Fibrillation Treatment Introduction
12.2.4 Abbott Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.2.5 Abbott Recent Development
12.3 Medtronic
12.3.1 Medtronic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Atrial Fibrillation Treatment Introduction
12.3.4 Medtronic Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.3.5 Medtronic Recent Development
12.4 Boston Scientific
12.4.1 Boston Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Atrial Fibrillation Treatment Introduction
12.4.4 Boston Scientific Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.4.5 Boston Scientific Recent Development
12.5 Siemens
12.5.1 Siemens Company Details
12.5.2 Company Description and Business Overview
12.5.3 Atrial Fibrillation Treatment Introduction
12.5.4 Siemens Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.5.5 Siemens Recent Development
12.6 Biotronik
12.6.1 Biotronik Company Details
12.6.2 Company Description and Business Overview
12.6.3 Atrial Fibrillation Treatment Introduction
12.6.4 Biotronik Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.6.5 Biotronik Recent Development
12.7 Koninklijke Philips
12.7.1 Koninklijke Philips Company Details
12.7.2 Company Description and Business Overview
12.7.3 Atrial Fibrillation Treatment Introduction
12.7.4 Koninklijke Philips Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.7.5 Koninklijke Philips Recent Development
12.8 AtriCure
12.8.1 AtriCure Company Details
12.8.2 Company Description and Business Overview
12.8.3 Atrial Fibrillation Treatment Introduction
12.8.4 AtriCure Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.8.5 AtriCure Recent Development
12.9 CardioFocus
12.9.1 CardioFocus Company Details
12.9.2 Company Description and Business Overview
12.9.3 Atrial Fibrillation Treatment Introduction
12.9.4 CardioFocus Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.9.5 CardioFocus Recent Development
12.10 MicroPort Scientific
12.10.1 MicroPort Scientific Company Details
12.10.2 Company Description and Business Overview
12.10.3 Atrial Fibrillation Treatment Introduction
12.10.4 MicroPort Scientific Revenue in Atrial Fibrillation Treatment Business (2014-2019)
12.10.5 MicroPort Scientific Recent Development
12.11 Sichuan Jinjiang Electronic Science and Technology

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details